Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer
Maciej Cieśla, Phuong Cao Thi Ngoc, Eugenia Cordero, et al.
Molecular Cell (2021) Vol. 81, Iss. 7, pp. 1453-1468.e12
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

RNA splicing dysregulation and the hallmarks of cancer
Robert K. Bradley, Olga Anczuków
Nature reviews. Cancer (2023) Vol. 23, Iss. 3, pp. 135-155
Open Access | Times Cited: 264
Protein synthesis control in cancer: selectivity and therapeutic targeting
Joanna Kovalski, Duygu Kuzuoğlu‐Öztürk, Davide Ruggero
The EMBO Journal (2022) Vol. 41, Iss. 8
Open Access | Times Cited: 82
Hallmarks of cancer stemness
Jia-Jian Loh, Stephanie Ma
Cell stem cell (2024) Vol. 31, Iss. 5, pp. 617-639
Closed Access | Times Cited: 68
Interaction of STIL with FOXM1 regulates SF3A3 transcription in the hepatocellular carcinoma development
Haijun Zhang, Lin Zhang, Zhichao Wu
Cell Division (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 2
m6A-driven SF3B1 translation control steers splicing to direct genome integrity and leukemogenesis
Maciej Cieśla, Phuong Cao Thi Ngoc, Sowndarya Muthukumar, et al.
Molecular Cell (2023) Vol. 83, Iss. 7, pp. 1165-1179.e11
Open Access | Times Cited: 24
MYC regulates a pan-cancer network of co-expressed oncogenic splicing factors
Laura M. Urbanski, Mattia Brugiolo, SungHee Park, et al.
Cell Reports (2022) Vol. 41, Iss. 8, pp. 111704-111704
Open Access | Times Cited: 37
CircSCAP interacts with SF3A3 to inhibit the malignance of non-small cell lung cancer by activating p53 signaling
Dongni Chen, Hongli Zhou, Zhuo‐Chen Cai, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 29
METTL3 regulates breast cancer-associated alternative splicing switches
Cyrinne Achour, Devi Prasad Bhattarai, P Groza, et al.
Oncogene (2023) Vol. 42, Iss. 12, pp. 911-925
Open Access | Times Cited: 22
MYC-driven U2SURP regulates alternative splicing of SAT1 to promote triple-negative breast cancer progression
Ling Deng, Li Liao, Yinling Zhang, et al.
Cancer Letters (2023) Vol. 560, pp. 216124-216124
Closed Access | Times Cited: 20
TDP43 promotes stemness of breast cancer stem cells through CD44 variant splicing isoforms
Lu Guo, Ke Hao, Honglei Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 23
eIF3d: A driver of noncanonical cap–dependent translation of specific mRNAs and a trigger of biological/pathological processes
Shijie Ma, Jingyuan Liu, Jian‐Ting Zhang
Journal of Biological Chemistry (2023) Vol. 299, Iss. 5, pp. 104658-104658
Open Access | Times Cited: 16
The eukaryotic translation initiation factor eIF4E reprograms alternative splicing
Mehdi Ghram, Gavin Morris, Biljana Culjkovic‐Kraljacic, et al.
The EMBO Journal (2023) Vol. 42, Iss. 7
Open Access | Times Cited: 15
Oncofetal SNRPE promotes HCC tumorigenesis by regulating the FGFR4 expression through alternative splicing
Qipeng Wu, Ruyan Liao, Chunmeng Miao, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 1, pp. 77-89
Closed Access | Times Cited: 4
Immune evasion: An imperative and consequence of MYC deregulation
Bastian Krenz, Jongkuen Lee, Toshitha Kannan, et al.
Molecular Oncology (2024)
Open Access | Times Cited: 4
The small Cajal body-specific RNA 15 (SCARNA15) directs p53 and redox homeostasis via selective splicing in cancer cells
Giulia Beneventi, Roberto Munita, Phuong Cao Thi Ngoc, et al.
NAR Cancer (2021) Vol. 3, Iss. 3
Open Access | Times Cited: 25
MIA40 suppresses cell death induced by apoptosis-inducing factor 1
Ben Hur Marins Mussulini, Klaudia K. Maruszczak, Piotr Drączkowski, et al.
EMBO Reports (2025)
Closed Access
Trans-ancestry transcriptome-wide association and functional studies to uncover novel susceptibility genes and therapeutic targets for colorectal cancer
Lijuan Wang, Lidan Hu, Jing Sun, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors
Anıl Aktaş Samur, Mariateresa Fulciniti, Hervé Avet‐Loiseau, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 12
Open Access | Times Cited: 15
Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens
Darwin Kwok, Nicholas Stevers, Takahide Nejo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Intron Retention of DDX39A Driven by SNRPD2 is a Crucial Splicing Axis for Oncogenic MYC/Spliceosome Program in Hepatocellular Carcinoma
Cunjie Chang, Lina Li, Ling Su, et al.
Advanced Science (2024)
Open Access | Times Cited: 3
Drp1 splice variants regulate ovarian cancer mitochondrial dynamics and tumor progression
Zaineb Javed, Dong Hui Shin, Weihua Pan, et al.
EMBO Reports (2024) Vol. 25, Iss. 10, pp. 4281-4310
Open Access | Times Cited: 3
Targeting SNRNP200-induced splicing dysregulation offers an immunotherapy opportunity for glycolytic triple-negative breast cancer
Wenxiao Yang, Hong Luo, Linwei Guo, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Tissue-Specific Analysis of Alternative Splicing Events and Differential Isoform Expression in Large Yellow Croaker (Larimichthys crocea) After Cryptocaryon irritans Infection
Ang Qu, Yulin Bai, Xinyi Zhang, et al.
Marine Biotechnology (2022) Vol. 24, Iss. 3, pp. 640-654
Closed Access | Times Cited: 14
Targeting the GTPase RAN by liposome delivery for tackling cancer stemness-emanated therapeutic resistance
Kaili Wang, Sitong Zhu, Ying Zhang, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 589-600
Closed Access | Times Cited: 2
Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancer
Cinzia Caggiano, Valerio Petrera, Miriana Ferri, et al.
Cell Reports (2024) Vol. 43, Iss. 9, pp. 114751-114751
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top